Public Relations (PR)
The agency network said the private equity firm won't be involved in its day-to-day operations, but it will help its growth strategy.
It is the group's first acquisition since it was assembled in February under CEO Karen van Bergen.
The Cleveland Clinic's CEO discusses how he keeps the hospital on top of its game and educates the community it serves.
The healthcare-focused agency network is committed to spending $50,000 over three years to the Future Leaders in Healthcare Fellowship Program.
AstraZeneca appointed Jennie Younger, who has held senior communications roles at GlaxoSmithKline, Deutsche Bank, and FTI Consulting, as its vice president of global corporate affairs.
The agency brought on Penny Mitchell to lead its U.S. health practice.
The Ketchum veteran joined the nonprofit healthcare system in mid-2014.
FitzPatrick is departing the company as it evaluates its 150 agency partnerships.
Former Biosector 2 US MD Jeanine O'Kane was named inVentiv Health PR Group's US MD.
Nashville-based ReviveHealth posted $8.7 million in revenue in 2014.
The firm began working with the pharma company before outrage over its drug pricing but has more recently supported the client after former CEO Martin Shkreli was arrested.
The former MSL regional leader reemerges as head of communications at Japan's largest pharma company.
Pfizer selected MacKay Jimeson and Niesha Foster as corporate affairs category leads after a reorganization of the company's global innovative pharma business.
The agency will team up with Tsinghua Institute of Health Communication on study on how consumers interact with healthcare content.
Drug pricing has been in the spotlight since early this fall, thanks to Turing Pharmaceuticals and Martin Shkreli. One thing pharma companies can do is to communicate more proactively.
Three suggestions for defusing the highly charged pricing atmosphere
Theranos posted the lengthy response on the news section of its website on Thursday, then bragged on Twitter that its statement was 3,000 words longer than the WSJ story.
The drugmaker, which recently drew scrutiny from lawmakers, is planning to change some of its most contentious business practices. Experts say Valeant also needs to educate lawmakers and the public about the value of its medicines.
Sherry Goldberg will replace her as New York market leader.
Kristie Kuhl, previously EVP at Cohn & Wolfe, is tasked with building out the agency's pharmaceutical business.
Sanofi's Aubagio reduces brain volume loss; cancer specialists avoid pricey cancer meds; analysis says placebo effect is on the rise
Craig Rothenberg joined Turing as its first comms chief less than two months ago.
Stakeholder activists, social media and an increasingly global market are three defining issues for companies operating in the 21st century.
Holland most recently worked as executive director of public health solutions at WebMD.
After two decades at Johnson & Johnson, Craig Rothenberg talks about joining a startup and the role of comms in pharma.
Walgreens Boots Alliance's global comms team works hand in hand to balance the complexities of a merger and create a unified strategy to inspire all stakeholders.
Contrary to popular belief, Addyi is not the female Viagra. That's the message drug-maker Sprout must get across to doctors and patients in the coming weeks.
ViiV Healthcare, a joint venture by Pfizer and GlaxoSmithKline, has appointed Porter Novelli to manage its corporate comms account, PRWeek understands.
From evolving healthcare laws to social engagement, litigation crises to media relations, McKesson's PR chief is hands-on in efforts to enhance the brand's image.
It's not always regulation or concerns about legal risks. Sometimes, a drugmaker's internal conservative culture is the biggest hurdle to overcome.
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Allergan draws on A-list celebs to drive engagement
- Non-profit behind 'Free Killer Tan' wants parents to practice sun safety
- Five things for pharma marketers to know: Monday, June 20, 2016
- Galderma exec: Skip the market research (sometimes)